论文信息 - Sorafenib and everolimus combination in non-resectable high-grade osteosarcoma progressing after standard treatment: a non-randomized phase II clinical trial from the Italian Sarcoma Group. Abstract - 字舞流文

Sorafenib and everolimus combination in non-resectable high-grade osteosarcoma progressing after standard treatment: a non-randomized phase II clinical trial from the Italian Sarcoma Group. Abstract

P. Casali | S. Ferrari | P. Picci | M. Aglietta | R. Biagini | V. Ferraresi | G. Grignani | F. Fagioli | R. Bertulli | M. Gambarotti | E. Palmerini | S. Asaftei | A. Tamburini | D. Sangiolo | Y. Pignochino | L. D'ambrosio | E. Marchesi | F. Capozzi